Knowledge Base

Resources & Guides

Educational content about GLP-1 medications, pharmacokinetics, and optimizing your treatment journey.

Showing articles tagged: #split dosing Clear filter

Educational Content

View all →
Showing 5 of 5 articles
No articles found matching your search. Try a different term or view all articles.

Split Dosing Semaglutide Twice Weekly: What the Label Says

Split dosing semaglutide twice weekly takes the same total weekly dose and divides it into two injections about 3 to 4 days apart. Every semaglutide product is FDA-approved for once-weekly dosing only, so this is off-label. Here is the pharmacokinetic reasoning, the pen-mechanics problem, and what has never been tested.

Microdosing GLP-1 Side Effects: What the Dose-Response Data Shows

A pharmacokinetics-anchored look at microdosing GLP-1 side effects across semaglutide, tirzepatide, and retatrutide: what trial dose-response data tells us about lower-dose GI tolerability, and which class-level serious risks persist at every dose.

Can You Split Retatrutide Twice Weekly? Schedule + Evidence

A twice-weekly retatrutide split takes the same total weekly dose and divides it into two injections about 3 to 4 days apart. The 6-day half-life is what makes that spacing logical. Here is the pharmacokinetic reasoning, the practical mechanics, and the honest evidence picture.

Microdosing GLP-1 Reddit: What the Community Actually Reports

A community synthesis of what Reddit threads actually report about GLP-1 microdosing: fewer side effects, the "just 10 lbs" cohort, off-label inflammation use, and where anecdote meets pharmacokinetics. Anecdotes, not medical advice.

What Is Microdosing GLP-1? Definition, Benefits, and Risks Explained

What microdosing GLP-1 actually means, how it differs from standard titration, what clinical evidence exists, and the risks of using sub-standard doses of semaglutide, tirzepatide, or retatrutide.